18 results
S-3
EX-1.2
SQZB
SQZ Biotechnologies Co
12 Nov 21
Shelf registration
12:00am
to be disclosed in the Registration Statement and the Prospectus.
(ii) Anti-Corruption and Anti-Bribery Laws. Neither the Company nor any of its subsidiaries nor … of 1977, as amended (the “FCPA”), the UK Bribery Act 2010, or any other applicable anti-bribery or anti-corruption law; or (iv) made, offered
10-K
2020 FY
SQZB
SQZ Biotechnologies Co
18 Mar 21
Annual report
6:31am
reimbursement, pricing and insurance regimes;
potential noncompliance with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act 2010 and similar … anti-bribery and anticorruption laws in other jurisdictions; and
production shortages resulting from any events affecting raw material supply
424B4
SQZB
SQZ Biotechnologies Co
12 Feb 21
Prospectus supplement with pricing info
5:10pm
;
foreign reimbursement, pricing and insurance regimes;
potential noncompliance with the U.S. Foreign Corrupt Practices Act, the U.K. Bribery Act 2010 … and similar anti-bribery and anticorruption laws in other jurisdictions; and
production shortages resulting from any events affecting raw material
DRS
p0f arnvzjyaunzl
1 Feb 21
Draft registration statement
12:00am
10-Q
1lnjru5iif
10 Dec 20
Quarterly report
4:46pm
424B4
5xph 1mu01bg1tv
30 Oct 20
Prospectus supplement with pricing info
4:54pm
S-1
EX-4.1
71lf9j
9 Oct 20
IPO registration
4:59pm
S-1
nrcmu7j
9 Oct 20
IPO registration
4:59pm
DRS/A
21uadcllubhma
25 Sep 20
Draft registration statement (amended)
12:00am
DRS/A
h0485iqbl8qhqf
28 Aug 20
Draft registration statement (amended)
12:00am
DRS
rw99scrd
21 Jul 20
Draft registration statement
12:00am
- Prev
- 1
- Next